IDEXX Labs logo

IDEXX Labs

Stock
Stock
ISIN: US45168D1046
Ticker: IDXX
US45168D1046
IDXX

Price

Price

CHART BY

Frequently asked questions

What is IDEXX Labs's market capitalization?

The market capitalization of IDEXX Labs is $33.76B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is IDEXX Labs's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for IDEXX Labs is 39.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for IDEXX Labs?

IDEXX Labs's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $10.36. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for IDEXX Labs's stock?

Currently, 16 analysts cover IDEXX Labs's stock, with a consensus target price of $499.18. Analyst ratings provide insights into the stock's expected performance.

What is IDEXX Labs's revenue over the trailing twelve months?

Over the trailing twelve months, IDEXX Labs reported a revenue of $3.84B.

What is the EBITDA for IDEXX Labs?

IDEXX Labs's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.24B. EBITDA measures the company's overall financial performance.

What is the free cash flow of IDEXX Labs?

IDEXX Labs has a free cash flow of $792.60M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does IDEXX Labs have, and what sector and industry does it belong to?

IDEXX Labs employs approximately 11,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of IDEXX Labs's shares?

The free float of IDEXX Labs is 81.07M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$33.76B
EPS (TTM) 
$10.36
Free Float 
81.07M
P/E ratio (TTM) 
39.78
Revenue (TTM) 
$3.84B
EBITDA (TTM) 
$1.24B
Free Cashflow (TTM) 
$792.60M

Pricing

1D span
$404.57$418.02
52W span
$399.89$583.25

Analyst Ratings

The price target is $499.18 and the stock is covered by 16 analysts.

Buy

8

Hold

7

Sell

1

Information

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Employees
11,000
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US45168D1046
Primary Ticker
IDXX

Knockouts

Join the conversation